FDA Wants Relaxed Sterility Test Rules For Bio Products
The U.S. Food and Drug Administration on Tuesday rolled out a proposal to update and loosen sterility test requirements for biological products like vaccines and stem-cell treatments, as part of efforts...To view the full article, register now.
Already a subscriber? Click here to view full article